Introduction: Atomoxetine (Strattera) is the first non-stimulant drug to be approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children 6 years of age and adolescents. Atomoxetine is a highly specific inhibitor of the presynaptic norepinephrine transporter, with minimal affinity for other transporters or other neurotransmitter receptors. The target dose is 1.
View Article and Find Full Text PDFPsychother Psychosom
December 2007
Background: Although there is a great heterogeneity of depressive states in bipolar patients, there is only one definition in international classifications for describing them. However, this variety seems particularly important to recognize because of the possible exacerbation of some of these bipolar depressive states by antidepressants. We aimed at assessing whether it is possible to distinguish different forms of bipolar depression using a dimensional approach.
View Article and Find Full Text PDFThe association of diabetes mellitus and mental illness, in particular, schizophrenia, has been remarked upon for over a century. Recent epidemiological studies have shown the age- and sex-matched prevalence of diabetes in patients with schizophrenia to be 1.5-2 times those in the general population.
View Article and Find Full Text PDFSoc Psychiatry Psychiatr Epidemiol
November 2003
Background: If impairment in social cognition is an important feature of psychosis, characteristics of the social environment may influence the occurrence of psychotic symptoms. The aim of this study was to explore in a non-clinical population whether specific social environments modify the expression of psychotic symptoms in daily life.
Methods: The Experience Sampling Method was used to collect information on characteristics of the social company and of the daily life psychotic experiences of a sample of 79 students.